A plus AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation

被引：0

作者：

Heyman, Benjamin ^{[1
]}

Choi, Michael ^{[2
]}

Kipps, Thomas J. ^{[3
]}

机构：

[1] UC San Diego Moores Canc Ctr, Dept Med, Div Regenerat Med, UC San Diego, La Jolla, CA 92093 USA

[2] Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

[3] Ctr Novel Therapeut, Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

来源：

CASE REPORTS IN HEMATOLOGY | 2024年 / 2024卷

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN; PHASE-II; CHEMOTHERAPY; VENETOCLAX; OUTCOMES; THERAPY; DISEASE; ABVD; MOPP;

D O I：

10.1155/2024/7612622

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hodgkin lymphoma variant of Richter's transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the combination of brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A + AVD). In our series of 4 patients, two patients treated with A + AVD for HvRT had durable remissions of 40 and 42 months, while two patients had disease progression and ultimately died. Continued investigation into the optimal management for patients with HvRT is still needed.

引用

页数：8

共 29 条

[1] Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results [J].

Advani, Ranjana H. ;

Moskowitz, Alison J. ;

Bartlett, Nancy L. ;

Vose, Julie M. ;

Ramchandren, Radhakrishnan ;

Feldman, Tatyana A. ;

LaCasce, Ann S. ;

Christian, Beth A. ;

Ansell, Stephen M. ;

Moskowitz, Craig H. ;

Brown, Lisa ;

Zhang, Chiyu ;

Taft, David ;

Ansari, Sahar ;

Sacchi, Mariana ;

Ho, Linda ;

Herrera, Alex F. .

BLOOD, 2021, 138 (06) :427-438

[2] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[3] Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature [J].

Bockorny, Bruno ;

Codreanu, Ion ;

Dasanu, Constantin A. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (01) :50-66

[4] Treatment of Chronic Lymphocytic Leukemia [J].

Burger, Jan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :460-473

[5] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].

CANELLOS, GP ;

ANDERSON, JR ;

PROPERT, KJ ;

NISSEN, N ;

COOPER, MR ;

HENDERSON, ES ;

GREEN, MR ;

GOTTLIEB, A ;

PETERSON, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484

[6] Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma [J].

Chen, Robert ;

Gopal, Ajay K. ;

Smith, Scott E. ;

Ansell, Stephen M. ;

Rosenblatt, Joseph D. ;

Savage, Kerry J. ;

Connors, Joseph M. ;

Engert, Andreas ;

Larsen, Emily K. ;

Huebner, Dirk ;

Fong, Abraham ;

Younes, Anas .

BLOOD, 2016, 128 (12) :1562-1566

[7] Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome [J].

Davids, Matthew S. ;

Rogers, Kerry A. ;

Tyekucheva, Svitlana ;

Wang, Zixu ;

Pazienza, Samantha ;

Renner, Sarah K. ;

Montegaard, Josie ;

Ihuoma, Udochukwu ;

Lehmberg, Timothy Z. ;

Parry, Erin M. ;

Wu, Catherine J. ;

Jacobson, Caron A. ;

Fisher, David C. ;

Thompson, Philip A. ;

Brown, Jennifer R. .

BLOOD, 2022, 139 (05) :686-689

[8] Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated with EBV infection [J].

de Leval, L ;

Vivario, M ;

De Prijck, B ;

Zhou, YP ;

Boniver, J ;

Harris, NL ;

Isaacson, P ;

Du, MQ .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (05) :679-686

[9] Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial [J].

Farooqui, Mohammed Z. H. ;

Valdez, Janet ;

Martyr, Sabrina ;

Aue, Georg ;

Saba, Nakhle ;

Niemann, Carsten U. ;

Herman, Sarah E. M. ;

Tian, Xin ;

Marti, Gerald ;

Soto, Susan ;

Hughes, Thomas E. ;

Jones, Jade ;

Lipsky, Andrew ;

Pittaluga, Stefania ;

Stetler-Stevenson, Maryalice ;

Yuan, Constance ;

Lee, Yuh Shan ;

Pedersen, Lone B. ;

Geisler, Christian H. ;

Calvo, Katherine R. ;

Arthur, Diane C. ;

Maric, Irina ;

Childs, Richard ;

Young, Neal S. ;

Wiestner, Adrian .

LANCET ONCOLOGY, 2015, 16 (02) :169-176

[10]

Herrera AF, 2023, J CLIN ONCOL, V41

← 1 2 3 →